Skip to main content

and
  1. Article

    Open Access

    Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response

    Although insulin resistance often leads to type 2 diabetes mellitus, its early stages are often unrecognised, thus reducing the probability of successful prevention and intervention. Moreover, treatment effica...

    Dominik Lutter, Stephan Sachs, Marc Walter, Anna Kerege, Leigh Perreault in Diabetologia (2023)

  2. Article

    Open Access

    PATHWEIGH, pragmatic weight management in adult patients in primary care in Colorado, USA: study protocol for a stepped wedge cluster randomized trial

    Despite the overwhelming prevalence and health implications of obesity, it is rarely adequately addressed in a health care setting. PATHWEIGH is a pragmatic approach to weight management that uses tools built ...

    Krithika Suresh, Jodi Summers Holtrop, L. Miriam Dickinson, Emileigh Willems in Trials (2022)

  3. No Access

    Article

    Novel therapies with precision mechanisms for type 2 diabetes mellitus

    Type 2 diabetes mellitus (T2DM) is one of the greatest health crises of our time and its prevalence is projected to increase by >50% globally by 2045. Currently, 10 classes of drugs are approved by the US Food...

    Leigh Perreault, Jay S. Skyler, Julio Rosenstock in Nature Reviews Endocrinology (2021)

  4. Article

    Subcellular localisation and composition of intramuscular triacylglycerol influence insulin sensitivity in humans

    Subcellular localisation is an important factor in the known impact of bioactive lipids, such as diacylglycerol and sphingolipids, on insulin sensitivity in skeletal muscle; yet, the role of localised intramus...

    Darcy Kahn, Leigh Perreault, Emily Macias, Simona Zarini, Sean A. Newsom in Diabetologia (2021)

  5. No Access

    Article

    Physiological factors contributing to HbA1c in the normal and pre-diabetic range: a cross-sectional analysis

    Little is known about the underlying physiology that contributes to Haemoglobin A1c (HbA1c) in the normal and pre-diabetic range. We determined the contribution of fasting plasma glucose (FPG), 2-h plasma glucose...

    Lea Bruhn, Dorte Vistisen, Camilla Trine Ravn Vainø, Leigh Perreault in Endocrine (2020)

  6. Article

    Open Access

    Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study

    Reversion from prediabetes to normoglycaemia is accompanied by an improvement in cardiovascular risk factors, but it is unclear whether this translates into a reduction in risk of cardiovascular disease (CVD) ...

    Dorte Vistisen, Mika Kivimäki, Leigh Perreault, Adam Hulman in Diabetologia (2019)

  7. Article

    Open Access

    The Association Between Type 2 Diabetes and Cardiovascular Disease: The “For Your SweetHeart™” Survey

    It is unclear whether patients and their loved ones appreciate that cardiovascular disease (CVD) is the major cause of morbidity and mortality in type 2 diabetes mellitus (T2DM). The purpose of this survey was...

    Leigh Perreault, Marilyn K. Boardman, Jonathan Pak in Advances in Therapy (2019)

  8. Article

    Open Access

    Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes

    The progressive nature of type 2 diabetes (T2D) means that many patients will require basal insulin therapy at some point in the course of the disease due to β-cell failure. As basal insulin primarily targets ...

    Leigh Perreault, Helena Rodbard, Virginia Valentine, Eric Johnson in Advances in Therapy (2019)

  9. Article

    Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions

    We compared the associations of circulating biomarkers of inflammation, endothelial and adipocyte dysfunction and coagulation with incident diabetes in the placebo, lifestyle and metformin intervention arms of...

    Ronald B. Goldberg, George A. Bray, Santica M. Marcovina, Kieren J. Mather in Diabetologia (2019)

  10. Article

    Open Access

    Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

    Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professional...

    Nicola L. Harman, John Wilding, Dave Curry, James Harris, Jennifer Logue in Trials (2018)

  11. Article

    Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study

    The largest and longest clinical trial of metformin for the prevention of diabetes is the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study (DPP/DPPOS). In this review, we summarise data f...

    Vanita R. Aroda, William C. Knowler, Jill P. Crandall, Leigh Perreault in Diabetologia (2017)

  12. No Access

    Article

    Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

    We reviewed published literature to determine the relationship between A1c and cardiovascular disease (CVD) and summarize the need and implications for CVD risk reduction with interventions, focusing in the pr...

    Leigh Perreault, Kristine Færch, Edward W. Gregg in Current Diabetes Reports (2017)

  13. Article

    Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans

    Ceramides and other sphingolipids comprise a family of lipid molecules that accumulate in skeletal muscle and promote insulin resistance. Chronic endurance exercise training decreases muscle ceramides and othe...

    Bryan C. Bergman, Joseph T. Brozinick, Allison Strauss, Samantha Bacon in Diabetologia (2016)